Literature DB >> 8641811

Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens.

B Fleischer1, A Necker, C Leget, B Malissen, F Romagne.   

Abstract

A panel of 15 mouse T-cell hybridomas, each expressing a different human Vbeta gene segment (hVbeta) in an otherwise mouse T-cell receptor (i.e., mouse alpha chain and CD3 complex), was constructed by transfection of hVbeta/mouse Cbeta chimeric T-cell receptor (TCR)-beta genes into a mouse T-cell hybridoma recipient lacking the endogenous TCR-beta chain. Several qualities that are conferred by the hVbeta chain of the TCR are retained in the chimeric human-mouse TCR complex: a large panel of hVbeta-specific antibodies specifically stained the hVbeta expressed by the mouse T-cell hybridomas. Moreover, hVbeta-transfected mouse cells could readily produce interleukin 2 when stimulated by superantigens presented by antigen-presenting cells. These characteristics made it possible to refine the reactivity of 17 superantigen preparations with the available transfected Vbetas. Each superantigen gave a characteristic pattern of reactivity on the transfectants. Positive reactivities with some of these transfectants, which differ only by the expressed hVbeta, demonstrate unambiguously the superantigenic character of a protein or fraction and its potential to react with the corresponding Vbetas. Therefore, these hVbeta-transfected cells constituted a valuable tool for determining "specificity fingerprints" of known or putative superantigens. First, commonly used, commercially available superantigens such as staphylococcal enterotoxin B and toxic shock syndrome toxin-1 (TSST-1) showed additional Vbeta reactivities, compared with those of their recombinant counterparts. This stresses the importance of using defined preparations of superantigens for the definition of Vbeta specificities. Second, the stimulatory pattern of a strain of Streptococcus pyogenes demonstrated that this strain, unlike others, produces a potent Vbeta 8-specific superantigen that is an yet undefined at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641811      PMCID: PMC173867          DOI: 10.1128/iai.64.3.987-994.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin.

Authors:  F Letourneur; B Malissen
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.

Authors:  F Spertini; H Spits; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

7.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

8.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

9.  Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.

Authors:  Y W Choi; A Herman; D DiGiusto; T Wade; P Marrack; J Kappler
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

10.  Idiotype-like molecules on cells of a human T cell leukemia.

Authors:  R D Bigler; D E Fisher; C Y Wang; E A Rinnooy Kan; H G Kunkel
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  7 in total

1.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

2.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

3.  Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats.

Authors:  Xi Yang; Rebecca A Buonpane; Beenu Moza; A K M Nur-ur Rahman; Ningyan Wang; Patrick M Schlievert; John K McCormick; Eric J Sundberg; David M Kranz
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

Review 4.  Superantigens in human disease.

Authors:  A Bernal; T Proft; J D Fraser; D N Posnett
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.542

5.  Modulation of the human T cell response by a novel non-mitogenic anti-CD3 antibody.

Authors:  Hirokazu Shiheido; Chen Chen; Masaki Hikida; Takeshi Watanabe; Jun Shimizu
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

6.  Identification and characterization of novel superantigens from Streptococcus pyogenes.

Authors:  T Proft; S L Moffatt; C J Berkahn; J D Fraser
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

7.  Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.

Authors:  Kelcey G Patterson; Jennifer L Dixon Pittaro; Peter S Bastedo; David A Hess; S M Mansour Haeryfar; John K McCormick
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.